Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea
NCT03059537
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
71
Enrollment
OTHER
Sponsor class
Conditions
Bile Acid Malabsorption
Interventions
DRUG:
Oral chenodeoxycholic acid stimulation
Sponsor
Lars Kristian Munck